Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine (Q37777290)
Jump to navigation
Jump to search
scientific article published on 02 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine |
scientific article published on 02 August 2010 |
Statements
1 reference
Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine (English)
1 reference
Javier Cortes
1 reference
Chris Twelves
1 reference
Linda Vahdat
1 reference
Joanne L Blum
1 reference
Thomas Bachelot
1 reference
Mario Campone
1 reference
Henri Roché
1 reference
Ahmad Awada
1 reference
Robert Paridaens
1 reference
Anthony Goncalves
1 reference
Dale E Shuster
1 reference
Jantien Wanders
1 reference
Fang Fang
1 reference
Renuka Gurnani
1 reference
Elaine Richmond
1 reference
Patricia E Cole
1 reference
Simon Ashworth
1 reference
Mary Ann Allison
1 reference
2 August 2010
1 reference
1 reference
28
1 reference
25
1 reference
3922-3928
1 reference
Identifiers
1 reference
1 reference